{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:33:53Z","timestamp":1790631233079,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010265","name":"Guizhou Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017957","name":"Health Commission of Guizhou Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.virol.2024.110196","type":"journal-article","created":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T19:58:12Z","timestamp":1722455892000},"page":"110196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Cationic liposomes overcome neutralizing antibodies and enhance reovirus efficacy in ovarian cancer"],"prefix":"10.1016","volume":"598","author":[{"given":"Zhiru","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chulan","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weili","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2024.110196_bib1","article-title":"Targeting circulating monocytes with CCL2-loaded liposomes armed with an oncolytic adenovirus","volume":"40","author":"Alessandra","year":"2022","journal-title":"Nanomedicine"},{"issue":"34","key":"10.1016\/j.virol.2024.110196_bib2","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1200\/JCO.20.03246","article-title":"Clinical responses of oncolytic coxsackievirus A21 (V937) in patients with unresectable melanoma","volume":"39","author":"Andtbacka","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.virol.2024.110196_bib3","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1614856","article-title":"High-throughput assessment of the antibody profile in ovarian cancer ascitic fluids","volume":"8","author":"Antony","year":"2019","journal-title":"OncoImmunology"},{"key":"10.1016\/j.virol.2024.110196_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2021.198440","article-title":"Oncolytic reovirus induces ovarian cancer cell apoptosis in a TLR3-dependent manner","volume":"301","author":"An","year":"2021","journal-title":"Virus Res."},{"issue":"10","key":"10.1016\/j.virol.2024.110196_bib5","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02062-17","article-title":"Reovirus-induced apoptosis in the intestine limits establishment of enteric infection","volume":"92","author":"Brown","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2024.110196_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.803050","article-title":"Clinical trials of oncolytic viruses in breast cancer","volume":"11","author":"Carter","year":"2021","journal-title":"Frontiers in oncology"},{"issue":"5","key":"10.1016\/j.virol.2024.110196_bib7","first-page":"492","article-title":"Cytotoxic effect of in vitro expanded NK cell-carrying oncolytic reovirus on colorectal cancer cells","volume":"26","author":"Chen","year":"2019","journal-title":"Chinese J. Cancer Biother."},{"issue":"6","key":"10.1016\/j.virol.2024.110196_bib8","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/17425247.2019.1617269","article-title":"Achieving systemic delivery of oncolytic viruses","volume":"16","author":"Claudia","year":"2019","journal-title":"Expet Opin. Drug Deliv."},{"issue":"3","key":"10.1016\/j.virol.2024.110196_bib9","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1158\/1535-7163.MCT-21-0240","article-title":"Novel group C oncolytic adenoviruses carrying a microRNA inhibitor demonstrate enhanced oncolytic activity in vitro and in vivo","volume":"21","author":"Doerner","year":"2022","journal-title":"Mol. Cancer Therapeut."},{"issue":"3","key":"10.1016\/j.virol.2024.110196_bib10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s40471-017-0115-y","article-title":"Challenges and opportunities in studying the epidemiology of ovarian cancer subtypes","volume":"4","author":"Doherty","year":"2017","journal-title":"Curr Epidemiol Rep"},{"issue":"1","key":"10.1016\/j.virol.2024.110196_bib11","doi-asserted-by":"crossref","DOI":"10.1007\/s11864-014-0317-1","article-title":"Immunotherapy for ovarian cancer","volume":"16","author":"Drerup","year":"2015","journal-title":"Curr. Treat. Options Oncol."},{"issue":"30","key":"10.1016\/j.virol.2024.110196_bib12","doi-asserted-by":"crossref","first-page":"E6157","DOI":"10.1073\/pnas.1700363114","article-title":"Stem cell-released oncolytic herpes simplex virus has therapeutic efficacy in brain metastatic melanomas","volume":"114","author":"Du","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"10","key":"10.1016\/j.virol.2024.110196_bib13","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1038\/mt.2014.118","article-title":"Cytokine conditioning enhances systemic delivery and therapy of an oncolytic virus","volume":"22","author":"Elizabeth","year":"2014","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.virol.2024.110196_bib14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3390\/ijms20010229","article-title":"Targeting mitochondria for treatment of chemoresistant ovarian cancer","volume":"20","author":"Emmings","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.virol.2024.110196_bib16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41416-020-0875-x","article-title":"The untapped potential of ascites in ovarian cancer research and treatment","volume":"123","author":"Ford","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"1\u20132","key":"10.1016\/j.virol.2024.110196_bib17","first-page":"238","article-title":"Cationic liposome-mediated delivery of reovirus enhances the tumor cell-killing efficiencies of reovirus in reovirus-resistant tumor cells","volume":"524","author":"Fuminori","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"25","key":"10.1016\/j.virol.2024.110196_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202300319","article-title":"A comparison of cellular uptake mechanisms, delivery efficacy, and intracellular fate between liposomes and extracellular vesicles","volume":"12","author":"Gandek","year":"2023","journal-title":"Adv. Healthcare Mater."},{"issue":"1","key":"10.1016\/j.virol.2024.110196_bib19","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12964-023-01232-y","article-title":"Investigating the potential of oncolytic viruses for cancer treatment via MSC delivery","volume":"21","author":"Ghaleh","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.virol.2024.110196_bib20","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1038\/s41417-022-00507-9","article-title":"Gastrointestinal cancer-associated fibroblasts expressing Junctional Adhesion Molecule-A are amenable to infection by oncolytic reovirus","volume":"29","author":"Harryvan","year":"2022","journal-title":"Cancer Gene Ther."},{"issue":"1","key":"10.1016\/j.virol.2024.110196_bib21","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.pbj.0000000000000007","article-title":"Oncolytic virus immunotherapies in ovarian cancer: moving beyond adenoviruses","volume":"3","author":"Hoare","year":"2018","journal-title":"Porto Biomed. J."},{"issue":"3","key":"10.1016\/j.virol.2024.110196_bib22","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jconrel.2005.10.018","article-title":"Investigating the uptake and intracellular fate of pH-sensitive liposomes by flow cytometry and spectral bio-imaging","volume":"110","author":"Huth","year":"2006","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.virol.2024.110196_bib23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-1-59745-178-9_2","article-title":"Pharmacological inhibition of endocytic pathways: is it specific enough to be useful?","volume":"440","author":"Ivanov","year":"2008","journal-title":"Methods Mol. Biol."},{"issue":"5","key":"10.1016\/j.virol.2024.110196_bib24","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/ijc.28450","article-title":"Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites","volume":"134","author":"Jennings","year":"2014","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.virol.2024.110196_bib25","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/CAD.0000000000001296","article-title":"Oncolytic viral therapy engenders a clinical response in a recurrent ovarian cancer patient","volume":"33","author":"Johna","year":"2022","journal-title":"Anti Cancer Drugs"},{"issue":"12","key":"10.1016\/j.virol.2024.110196_bib26","article-title":"Trial watch: oncolytic viro-immunotherapy of hematologic and solid tumors","volume":"7","author":"Jonathan","year":"2018","journal-title":"OncoImmunology"},{"key":"10.1016\/j.virol.2024.110196_bib27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11912-022-01341-w","article-title":"Oncolytic viruses and cancer immunotherapy","volume":"25","author":"Jyoti","year":"2023","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.virol.2024.110196_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108882","article-title":"Oncolytic virus delivery modulated immune responses toward cancer therapy: challenges and perspectives","volume":"108","author":"Keshavarz","year":"2022","journal-title":"Int. Immunopharm."},{"issue":"8","key":"10.1016\/j.virol.2024.110196_bib30","doi-asserted-by":"crossref","first-page":"454","DOI":"10.5483\/BMBRep.2015.48.8.076","article-title":"Naturally occurring reoviruses for human cancer therapy","volume":"48","author":"Kim","year":"2015","journal-title":"BMB Rep."},{"issue":"16","key":"10.1016\/j.virol.2024.110196_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201908788","article-title":"Poly(cyclodextrin)-polydrug nanocomplexes as synthetic oncolytic virus for locoregional melanoma chemoimmunotherapy","volume":"30","author":"Kim","year":"2020","journal-title":"Adv. Funct. Mater."},{"issue":"13","key":"10.1016\/j.virol.2024.110196_bib32","doi-asserted-by":"crossref","first-page":"8388","DOI":"10.1128\/JVI.79.13.8388-8399.2005","article-title":"Flavivirus activates phosphatidylinositol 3-kinase signaling to block caspase-dependent apoptotic cell death at the early stage of virus infection","volume":"79","author":"Lee","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2024.110196_bib33","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41585-021-00483-z","article-title":"Using oncolytic viruses to ignite the tumour immune microenvironment in bladder cancer","volume":"18","author":"Li","year":"2021","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.virol.2024.110196_bib34","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.critrevonc.2019.05.014","article-title":"Ovarian cancer relapse: from the latest scientific evidence to the best practice","volume":"140","author":"Luvero","year":"2019","journal-title":"Crit. Rev. Oncol.-Hematol."},{"key":"10.1016\/j.virol.2024.110196_bib35","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jconrel.2022.12.050","article-title":"Pre-treatment of oncolytic reovirus improves tumor accumulation and intratumoral distribution of PEG-liposomes","volume":"354","author":"Maho","year":"2023","journal-title":"J. Contr. Release"},{"issue":"4","key":"10.1016\/j.virol.2024.110196_bib36","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2217\/fvl-2016-0129","article-title":"Designing and building oncolytic viruses","volume":"12","author":"Maroun","year":"2017","journal-title":"Future Virol."},{"key":"10.1016\/j.virol.2024.110196_bib37","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12935-023-02854-5","article-title":"Tumor microenvironment in ovarian cancer peritoneal metastasis","volume":"23","author":"Mei","year":"2023","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.virol.2024.110196_bib38","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jconrel.2015.04.015","article-title":"Intracellular trafficking of hybrid gene delivery vectors","volume":"207","author":"Rahul","year":"2015","journal-title":"J. Contr. Release"},{"issue":"10","key":"10.1016\/j.virol.2024.110196_bib40","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1158\/2326-6066.CIR-18-0309","article-title":"Antibody-neutralized reovirus is effective in oncolytic virotherapy","volume":"6","author":"Robert","year":"2018","journal-title":"Cancer Immunol. Res."},{"issue":"7","key":"10.1016\/j.virol.2024.110196_bib41","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002673","article-title":"Antiviral antibody responses to systemic administration of an oncolytic RNA virus: the impact of standard concomitant anticancer chemotherapies","volume":"9","author":"Roulstone","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"1\u20132","key":"10.1016\/j.virol.2024.110196_bib42","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ijpharm.2017.04.006","article-title":"Cationic liposome-mediated delivery of reovirus enhances the tumor cell-killing efficiencies of reovirus in reovirus-resistant tumor cells","volume":"524","author":"Sakurai","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.virol.2024.110196_bib43","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1128\/JVI.78.5.2310-2318.2004","article-title":"Characterization of rotavirus cell entry","volume":"78","author":"S\u00e1nchez-San","year":"2004","journal-title":"J. Virol."},{"issue":"17","key":"10.1016\/j.virol.2024.110196_bib44","doi-asserted-by":"crossref","first-page":"6425","DOI":"10.1073\/pnas.83.17.6425","article-title":"Temperature-sensitive steps in the transport of secretory proteins through the Golgi complex in exocrine pancreatic cells","volume":"83","author":"Saraste","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virol.2024.110196_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.940019","article-title":"Herpes simplex virus 1 as an oncolytic viral therapy for refractory cancers","volume":"12","author":"Scanlan","year":"2022","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.virol.2024.110196_bib46","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.3390\/nano10061183","article-title":"Gold nanoparticle-assisted virus formation by means of the delivery of an oncolytic adenovirus genome","volume":"10","author":"Sendra","year":"2020","journal-title":"Nanomaterials"},{"issue":"1","key":"10.1016\/j.virol.2024.110196_bib47","first-page":"17","article-title":"Cancer statistics","volume":"73","author":"Siegel","year":"2023","journal-title":"CA A Cancer J. Clin."},{"issue":"11","key":"10.1016\/j.virol.2024.110196_bib48","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1038\/sj.gt.3301015","article-title":"Mechanisms of gene transfer mediated by lipoplexes associated with targeting ligands or pH-sensitive peptides","volume":"6","author":"Sim\u00f5es","year":"1999","journal-title":"Gene Ther."},{"issue":"116","key":"10.1016\/j.virol.2024.110196_bib49","first-page":"267","article-title":"Novel approaches to cancer immunotherapy","volume":"21","author":"Subramaniam","year":"2016","journal-title":"Discov. Med."},{"key":"10.1016\/j.virol.2024.110196_bib50","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.colsurfb.2017.04.058","article-title":"Endocytosis and intracellular traffic of cholesterol-PDMAEMA liposome complexes in human epithelial-like cells","volume":"156","author":"Szymanowski","year":"2017","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"3","key":"10.1016\/j.virol.2024.110196_bib51","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/jjco\/hyy170","article-title":"Oncolytic virus therapy in Japan: progress in clinical trials and future perspectives","volume":"49","author":"Taguchi","year":"2019","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.virol.2024.110196_bib52","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1083\/jcb.123.5.1107","article-title":"Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation","volume":"123","author":"Wang","year":"1993","journal-title":"JCB (J. Cell Biol.)"},{"key":"10.1016\/j.virol.2024.110196_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107437","article-title":"Mesenchymal stem cell carriers enhance antitumor efficacy induced by oncolytic reovirus in acute myeloid leukemia","volume":"94","author":"Wang","year":"2021","journal-title":"Int. Immunopharm."},{"issue":"2","key":"10.1016\/j.virol.2024.110196_bib54","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1021\/acs.molpharmaceut.8b01046","article-title":"Liposome encapsulation of oncolytic virus M1 to reduce immunogenicity and immune clearance in vivo","volume":"16","author":"Wang","year":"2019","journal-title":"Mol. Pharm."},{"issue":"9","key":"10.1016\/j.virol.2024.110196_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184816","article-title":"Cytokine-induced killer cell delivery enhances the antitumor activity of oncolytic reovirus","volume":"12","author":"Zhao","year":"2017","journal-title":"PLoS One"}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682224002174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682224002174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T01:24:58Z","timestamp":1759368298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682224002174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":52,"alternative-id":["S0042682224002174"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2024.110196","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cationic liposomes overcome neutralizing antibodies and enhance reovirus efficacy in ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2024.110196","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110196"}}